IA NVR (Exjade 125 mg)

Generic Name: deferasirox

Pill imprint IA NVR has been identified as Exjade 125 mg.

Exjade is used in the treatment of hemosiderosis and belongs to the drug class chelating agents. There is no proven risk in humans during pregnancy. Exjade 125 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for IA NVR

Exjade
Generic Name:
deferasirox
Imprint:
IA
NVR
Strength:
125 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Chelating agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0468
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone k30
silicon dioxide
sodium lauryl sulfate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)